Cite
HARVARD Citation
Gainor, J. et al. (2016). Brief Reports - Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib. Journal of thoracic oncology. 11 (2), p. . [Online].